Free Trial

ImmuCell (ICCC) SEC Filings & 10K Form

ImmuCell logo
$3.58
-0.03 (-0.83%)
(As of 11/1/2024 ET)

Recent ImmuCell SEC Filings

DateFilerForm TypeView
09/24/2024
10:55 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
7:29 AM
ImmuCell (Issuer)
Rosgen Steven T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:29 AM
Gathagan Bryan K. (Reporting)
ImmuCell (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:30 AM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:30 AM
Basse Gloria F (Reporting)
ImmuCell (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
7:31 AM
ImmuCell (Issuer)
Wainman Paul R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
12:49 PM
ImmuCell (Subject)
SRK FUND I, LP (Filed by)
Form SCHEDULE 13D/A
08/30/2024
11:25 AM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:32 PM
ImmuCell (Subject)
Knudsen Ejnar A III (Filed by)
Form SC 13D
08/26/2024
2:00 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
12:05 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
12:04 PM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
12:38 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
10:33 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
6:49 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:50 PM
ImmuCell (Subject)
SRK FUND I, LP (Filed by)
Form SCHEDULE 13D
05/14/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM
ImmuCell (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
8:00 AM
ImmuCell (Filer)
Form DEF 14A
04/09/2024
6:50 PM
ImmuCell (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/09/2024
6:52 PM
ImmuCell (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/09/2024
11:15 PM
ImmuCell (Filer)
Form EFFECT
04/09/2024
4:19 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
12:55 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
2:22 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ICCC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners